Budesonide/Formoterol Fumarate Dihydrate Inhalation Aerosol clinical trials
Its developmentBy AstraZeneca, Chenpon Pharmaceutical and Orion Corporation, Orion Pharma, step by step10 company-led studies, furthest phase 4: when each phase was reached, its deals, target and what is ahead.How each study uses Budesonide/Formoterol Fumarate Dihydrate Inhalation Aerosol is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
13 studies that test it; most in 2009 (3)
| Year | Studies |
|---|---|
| 2006 | 1 |
| 2007 | 2 |
| 2009 | 3 |
| 2010 | 2 |
| 2011 | 1 |
| 2012 | 1 |
| 2018 | 2 |
| 2024 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 9 · Other 4
AstraZeneca (7) · Zhujiang Hospital (2) · Shanghai Xin Huanghe Pharmaceutical Co., Ltd. (1) · British Columbia Cancer Agency (1) · Orion Corporation, Orion Pharma (1) · The First Affiliated Hospital of Guangzhou Medical University (1)
Often tested with
Tested in the same studies.
Budesonide (1) · Conventional Therapy (1) · Montelukast (1)
Studies
Open first, then newest update. How each study uses Budesonide/Formoterol Fumarate Dihydrate Inhalation Aerosol is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 13
- Bioequivalence Study of Budesonide/Formoterol Inhalation Powder in Healthy ParticipantsCompletedPhase 1Shanghai Xin Huanghe Pharmaceutical Co., Ltd.NCT07804303Written as Budesonide and Formoterol Fumarate Powder for Inhalation (II) (Reference)How we know
- Differences of Small Airways Function Between Chronic Obstructive Pulmonary Disease(COPD) and Asthma-copd Overlap(ACO)Status unknownPhase 4Zhujiang HospitalNCT03563001Written as Budesonide(160ug) and Formoterol(4.5ug) bidHow we know
- Change of Lung Function After Exercise in Patients With Chronic Obstructive Pulmonary DiseaseStatus unknownPhase 4Zhujiang HospitalNCT03551197Written as Budesonide and formoterol bidHow we know
- Efficacy and Tolerability of Symbicort as an add-on Treatment to Spiriva Compare With Spiriva Alone in Patients With Severe Chronic Obstructive Pulmonary Disease (COPD)CompletedPhase 4AstraZenecaNCT01397890Written as Budesonide/formoterol (Symbicort® Turbuhaler®)How we know
- Effects of Leukotriene Modulator Montelukast on Cough Variant AsthmaStatus unknownPhase 4The First Affiliated Hospital of Guangzhou Medical UniversityNCT01404013Written as ICS/LABAHow we know
- A Safety and Efficacy Study of Symbicort Turbuhaler Compared With Standard Chronic Obstructive Pulmonary Disease (COPD) Treatment in JapanCompletedPhase 3AstraZenecaNCT01070784Written as Symbicort Turbuhaler (Budesonide/formoterol)How we know
- Study to Investigate the Efficacy of Symbicort® SMART.CompletedPhase 3AstraZenecaNCT00839800Written as Symbicort TurbuhalerHow we know
- Efficacy and Safety Study of Symbicort® Turbuhaler® Versus Oxis® Turbuhaler® in Chronic Obstructive Pulmonary Disease (COPD) PatientsCompletedPhase 3AstraZenecaNCT01069289Written as Budesonide/formoterol (Symbicort Turbuhaler)How we know
- Study to Investigate the Safety and Efficacy of High Dose of Symbicort® SMART in Japanese PatientsCompletedPhase 3AstraZenecaNCT00837967Written as Symbicort TurbuhalerHow we know
- Symbicort Rapihaler Therapeutic Equivalence StudyCompletedPhase 3AstraZenecaNCT00536731Written as Symbicort TurbuhalerHow we know
- Studying Genes in Blood and Lung Fluid Samples From Patients With Chronic Obstructive Pulmonary Disease With or Without a Previous Diagnosis of Lung Cancer or With Asthma Treated With Budesonide and FormoterolCompletedPhase 1British Columbia Cancer AgencyNCT00569712Written as budesonide/formoterol fumarate dihydrate inhalation aerosolHow we know
- Symbicort Single Inhaler Therapy vs Conventional Best Practice for the Treatment of Persistent Asthma in AdultsTerminatedPhase 3AstraZenecaNCT00385593Written as Symbicort (budesonide/formoterol) TurbuhalerHow we know
- Pharmacokinetic Pilot Study on Budesonide/Formoterol Device-metered Dry Powder InhalerCompletedPhase 1Orion Corporation, Orion PharmaNCT00868426Written as Budesonide/Formoterol Batch 1How we know
Given beside what is tested · 1 — Budesonide/Formoterol Fumarate Dihydrate Inhalation Aerosol is usual care or a partner of the new treatment
As the comparator · 5 — what is tested is compared with Budesonide/Formoterol Fumarate Dihydrate Inhalation Aerosol
- Study Comparing Dual Combination of Product (Budesonide and Formoterol) Given Via Two Different Inhalers. To See Which One Results in the Best Effect on Breathing.CompletedPhase 3AstraZenecaNCT04078126Written as Symbicort TurbuhalerHow we know
- Study to Assess Efficacy and Safety of PT009 Compared to PT005, PT008, and Symbicort® Turbuhaler® on Lung Function Over 24-Weeks in Subjects With Moderate to Very Severe COPDCompletedPhase 3Pearl Therapeutics, Inc.NCT02766608Written as Symbicort® TBH 400/12 μg BIDHow we know
- Pharmacokinetic Study to Compare Absorption of Budesonide/Formoterol Easyhaler and Symbicort TurbuhalerCompletedPhase 1Orion Corporation, Orion PharmaNCT03073057Written as Symbicort TurbuhalerHow we know
- Comparison of Absorption of Budesonide and Formoterol From Budesonide/Formoterol Easyhaler and Symbicort TurbuhalerCompletedPhase 1Orion Corporation, Orion PharmaNCT01593826Written as Charcoal and Symbicort TurbuhalerHow we know
- Pharmacokinetic Study Comparing Budesonide/Formoterol Easyhaler and Symbicort Turbuhaler ForteCompletedPhase 1Orion Corporation, Orion PharmaNCT01627158Written as Symbicort TurbuhalerHow we know